Copy to clipboard 
Elos Medtech’s Board appointed the Chairman, Stefano Alfonsi, as new President and CEO. Mr. Alfonsi will step down as Chairman of the Board and remain a Board Member. The Board has appointed the current Board Member, Magnus René, as new Chairman of the Board.
Alfonsi succeeds interim CEOs Jodie Gilmore and Søren Olesen, who will remain in their positions as President & Business Unit Directors. The changes in the Board and Management are subject to approval by the Swedish Companies Registration Office.
Stefano Alfonsi has extensive experience from the medical technology industry, where he has held positions as Chairman of the Board of Directors and CEO of Corin Group, CEO of Lima Corporate and Vice President positions in Johnson & Johnson’s DePuy.
Stefano Alfonsi said, “I am honored to be associated with Elos Medtech, initially as Chairman of the Board and now as CEO. Elos Medtech is on the path to strongly develop and enhance its leading position on the medical device market. Each employee at Elos Medtech across Asia, Europe and USA, are passionate and determined to exceed our customers’ expectations and I am proud to now become their CEO. I want to thank our Board for the trust showed in me, and Jodie and Søren for their leadership during this transition. I am looking forward to the future journey, continuing to grow this global medical technology company.”
Magnus René, Chairman of the Board of Elos Medtech, said, “We are very pleased that Stefano takes the position as the company’s new CEO. Stefano’s extensive experience makes him perfectly suited to lead the company in its next phase.”
Source: Elos Medtech
